Strategic Communication and Public Relations

Strong cooperation with Weizmann Institute of Science

No. 54c | 23/10/2018

from left to right.: Michael Baumann, Chairman and Scientific Director DKFZ, Daniel Zajfmann, President Weizmann Instituts, Eran Elinav, Head of the bridging division, Josef Puchta, Administrative Director DKFZ

DKFZ and the Weizmann Institute of Science (WIS) wish to combine their strengths and establish a strong cooperation in cancer-related microbiome research. Both institutions agreed to establish a bridging division at DKFZ. Eran Elinav, Professor at WIS, will receive the status of a Visiting/Guest Scientist at DKFZ and will head the bridging division from beginning of 2019. The main focus of the bridging division will rely on cancer-related microbiome research and collaborative projects together with other DKFZ groups.

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.

Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS